HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 30 filers reported holding HARPOON THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $23 | +360.0% | 33,791 | +399.7% | 0.00% | – |
Q1 2023 | $5 | +25.0% | 6,762 | +9.7% | 0.00% | – |
Q4 2022 | $4 | -100.0% | 6,162 | -57.3% | 0.00% | – |
Q3 2022 | $14,000 | -50.0% | 14,426 | 0.0% | 0.00% | – |
Q2 2022 | $28,000 | -68.2% | 14,426 | -17.4% | 0.00% | – |
Q1 2022 | $88,000 | -84.3% | 17,465 | -76.5% | 0.00% | – |
Q4 2021 | $562,000 | +128.5% | 74,262 | +138.3% | 0.00% | – |
Q3 2021 | $246,000 | -50.8% | 31,167 | -13.7% | 0.00% | – |
Q2 2021 | $500,000 | +39.7% | 36,105 | +111.3% | 0.00% | – |
Q1 2021 | $358,000 | +29.2% | 17,088 | +2.2% | 0.00% | – |
Q4 2020 | $277,000 | +9.9% | 16,716 | +12.8% | 0.00% | – |
Q3 2020 | $252,000 | -34.2% | 14,823 | -35.8% | 0.00% | – |
Q2 2020 | $383,000 | +133.5% | 23,101 | +62.6% | 0.00% | – |
Q1 2020 | $164,000 | -8.9% | 14,209 | +16.3% | 0.00% | – |
Q4 2019 | $180,000 | +102.2% | 12,220 | +87.2% | 0.00% | – |
Q3 2019 | $89,000 | +78.0% | 6,529 | +70.7% | 0.00% | – |
Q2 2019 | $50,000 | +614.3% | 3,824 | +403.2% | 0.00% | – |
Q1 2019 | $7,000 | – | 760 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 3,130,267 | $43,417,000 | 8.07% |
MPM BioImpact LLC | 3,196,707 | $44,338,000 | 7.28% |
Aquilo Capital Management, LLC | 712,674 | $9,885,000 | 2.57% |
Logos Global Management LP | 800,000 | $11,096,000 | 0.93% |
New Leaf Venture Partners, L.L.C. | 3,156,699 | $3,364,000 | 0.86% |
VR Adviser, LLC | 512,005 | $7,102,000 | 0.86% |
SECTORAL ASSET MANAGEMENT INC | 580,759 | $8,055,000 | 0.65% |
Avidity Partners Management LP | 1,500,000 | $20,805,000 | 0.56% |
Orbimed Advisors | 2,611,308 | $36,219,000 | 0.37% |
Maven Securities LTD | 618,610 | $8,456,000 | 0.34% |